TY - JOUR
T1 - Catatonia in Adolescence
T2 - First Onset Psychosis or Anti-NMDAr Encephalitis?
AU - Averna, Roberto
AU - Battaglia, Claudia
AU - Labonia, Milena
AU - Riccioni, Assia
AU - Vicari, Stefano
PY - 2019/5/30
Y1 - 2019/5/30
N2 - Catatonia is a rare condition that can occur in developmental disorders, but it is more frequently seen in schizophrenia. Recently, a high prevalence of cerebrospinal fluid abnormalities including the detection of antineuronal autoantibodies has been observed in psychotic patients. Among these autoimmune encephalopathies associated with a psychiatric condition, a great deal of attention has been paid to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis, which may present, among other things, symptoms such as catatonia, which therefore imposes a differential diagnosis with respect to the early psychosis. The aim of our study was to describe the clinical characteristics of 4 cases with catatonic symptoms to understand the differences between the psychotic symptoms due to a type of encephalitis anti-NMDAr and the psychotic symptoms without anti-NMDAr.
AB - Catatonia is a rare condition that can occur in developmental disorders, but it is more frequently seen in schizophrenia. Recently, a high prevalence of cerebrospinal fluid abnormalities including the detection of antineuronal autoantibodies has been observed in psychotic patients. Among these autoimmune encephalopathies associated with a psychiatric condition, a great deal of attention has been paid to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis, which may present, among other things, symptoms such as catatonia, which therefore imposes a differential diagnosis with respect to the early psychosis. The aim of our study was to describe the clinical characteristics of 4 cases with catatonic symptoms to understand the differences between the psychotic symptoms due to a type of encephalitis anti-NMDAr and the psychotic symptoms without anti-NMDAr.
U2 - 10.1097/WNF.0000000000000348
DO - 10.1097/WNF.0000000000000348
M3 - Article
C2 - 31157633
SN - 0362-5664
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
ER -